Comparison of whole genome amplification techniques for human single cell exome sequencing.
Level III
Where this comes from
- Record sourced from PubMed, PMID 28207771.
- Also identified by DOI 10.1371/journal.pone.0171566 and PMC identifier 5313163.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whole genome amplification (WGA) is currently a prerequisite for single cell whole genome or exome sequencing. Depending on the method used the rate of artifact formation, allelic dropout and sequence coverage over the genome may differ significantly. The largest difference between the evaluated protocols was observed when analyzing the target coverage and read depth distribution. These differences also had impact on the downstream variant calling. Conclusively, the products from the AMPLI1 and MALBAC kits were shown to be most similar to the bulk samples and are therefore recommended for WGA of single cells. In this study four commercial kits for WGA (AMPLI1, MALBAC, Repli-G and PicoPlex) were used to amplify human single cells. The WGA products were exome sequenced together with non-amplified bulk samples from the same source. The resulting data was evaluated in terms of genomic coverage, allelic dropout and SNP calling.
Medical subject headings
- Exome
- Genome, Human
- High-Throughput Nucleotide Sequencing
- Nucleic Acid Amplification Techniques
- Polymorphism, Single Nucleotide
- Single-Cell Analysis